Duncan Jodrell

13PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 30, 2026
Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer.

|Oct 31, 2025
Transcription factor switching drives subtype-specific pancreatic cancer.

Shalini V Rao, Lisa Young, Danya Cheeseman

|May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak

|May 24, 2024
Intratumoral antigen signaling traps CD8+ T cells to confine exhaustion to the tumor site.

Munetomo Takahashi, Tsz Y So, Vitalina Chamberlain-Evans

|Feb 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.

Alimu Dayimu, Lorena Di Lisio, Shubha Anand

|Feb 25, 2022
Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia.

Michele Petruzzelli, Miriam Ferrer, Martijn J Schuijs

Pageof 3

Frequent Collaborators

2 joint publications

Frances M Richards

2 joint publications

James E D Thaventhiran

2 joint publications

Kenneth G C Smith

2 joint publications

Simon Tavaré